Pure Global

Changes in the Threshold of Electrically Evoked Compound Action Potential in Children Following Cochlear Implantation - Trial NCT03500718

Access comprehensive clinical trial information for NCT03500718 through Pure Global AI's free database. This phase not specified trial is sponsored by Jawaharlal Institute of Postgraduate Medical Education & Research and is currently Completed. The study focuses on Cochlear Hearing Loss. Target enrollment is 44 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT03500718
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT03500718
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Changes in the Threshold of Electrically Evoked Compound Action Potential in Children Following Cochlear Implantation

Study Focus

Cochlear Hearing Loss

Cochlear implant

Interventional

device

Sponsor & Location

Jawaharlal Institute of Postgraduate Medical Education & Research

Puducherry, India

Timeline & Enrollment

N/A

Feb 26, 2018

Dec 31, 2019

44 participants

Primary Outcome

Changes in threshold of ECAP after cochlear implantation.

Summary

After cochlear implantation, cochlear nerve is stimulated by giving a current over the
 electrodes placed in the cochlea and the current is measured by electrically evoked Compound
 Action Potential (ECAP).This ECAP is measured intra operatively, after 4 weeks( at switch
 on), after 3months and 6 months following cochlear implantation.

ICD-10 Classifications

Other hearing loss
Other specified hearing loss
Ototoxic hearing loss
Hearing loss, unspecified
Sudden idiopathic hearing loss

Data Source

ClinicalTrials.gov

NCT03500718

Device Trial